Aktis Oncology is a company dedicated to transforming cancer care through the development of precision radiopharmaceuticals. Their innovative platform technologies enable the design and development of targeted therapies that harness the curative power of alpha-emitting particles. With a focus on commonly occurring cancers and tumours with limited treatment options, Aktis Oncology aims to revolutionize cancer treatment and put solid cancers into remission.